EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study

Debora Rondinella, Gianluca Quaranta, Tommaso Rozera, Pasquale Dargenio, Giovanni Fancello, Irene Venturini, Alessandra Guarnaccia, Serena Porcari, Stefano Bibbò, Maurizio Sanguinetti, Antonio Gasbarrini, Luca Masucci und 2 weitere

Microbes and Infection · 2024-07 · 26 (5-6) · 105341

DOI: 10.1016/j.micinf.2024.105341 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Microbes and Infection, 2024-07. Verfasst von Debora Rondinella und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, UOC…. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Feces, Clostridium Infections, Donor Selection. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero della Salute, Ministero dell'Istruzione dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fecal microbiota transplantation (FMT) is effective against recurrent Clostridioides difficile infection (rCDI), but its safety is jeopardized by the potential transmission of pathogens, so international guidelines recommend either a quarantine or a direct stool testing. Whereas reports of the quarantine-based approach are emerging, data on the direct testing-based approach are not available. Our aim is to report outcomes of a donor screening framework for FMT including direct stool testing. In this prospective cohort study, all donor candidates recruited at our FMT centre underwent a four-step screening process to be enrolled as actual donors. Each collected stool donation was then evaluated with a direct stool testing including a molecular assay for gut pathogens and a culture assay for multi-drug resistant organisms (MDRO). From January 2019 to June 2023, 72 of 227 candidates (32%) were considered eligible and provided 277 stool donations. Ninety-nine donations (36%) were discarded for positivity to intestinal pathogens, most commonly enteropathogenic Escherichia coli (n = 37) and Blastocystis hominis (n = 20). Overall, 337 stool aliquots were obtained from 165 approved donations. All suspensions were used for patients with rCDI, and no serious adverse events or clinically evident infections were observed at 12 weeks after procedures. In our study, screening of donor faeces including direct stool testing led to the discard of a considerable rate of stool donations but was also extremely safe. This approach may represent a reliable strategy to guarantee the safety of FMT programs, especially in countries with high prevalence of MDRO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationFecesClostridium InfectionsDonor SelectionHumansProspective StudiesFemaleMaleMiddle AgedAgedAdultClostridioides difficileGastrointestinal Microbiome

Stichwörter der Autor:innen

Donor programDonor screeningFecal microbiota transplantationGut pathogensStool bankStool biobank

Autor:innen und Institutionen

  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, UOC Gastroenterologia, Fondazione Policlinico Universitario Agostino Geme…
  • Microbiology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Ministero della Salute
  • Ministero dell'Istruzione dell'Università e della Ricerca

Zitieren

APA

Rondinella, D., Quaranta, G., Rozera, T., Dargenio, P., Fancello, G., Venturini, I., Guarnaccia, A., Porcari, S., Bibbò, S., Sanguinetti, M., Gasbarrini, A., Masucci, L., Cammarota, G., & Ianiro, G. (2024). Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study. Microbes and Infection, 26(5-6), 105341. https://doi.org/10.1016/j.micinf.2024.105341

Vancouver

Rondinella D, Quaranta G, Rozera T, Dargenio P, Fancello G, Venturini I, et al. Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study. Microbes and Infection. 2024;26(5-6):105341. doi:10.1016/j.micinf.2024.105341

BibTeX
@article{Rondinella2024,
  author = {Rondinella, Debora and Quaranta, Gianluca and Rozera, Tommaso and Dargenio, Pasquale and Fancello, Giovanni and Venturini, Irene and Guarnaccia, Alessandra and Porcari, Serena and Bibbò, Stefano and Sanguinetti, Maurizio and Gasbarrini, Antonio and Masucci, Luca and Cammarota, Giovanni and Ianiro, Gianluca},
  title = {Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study},
  journal = {Microbes and Infection},
  year = {2024},
  volume = {26},
  number = {5-6},
  pages = {105341},
  doi = {10.1016/j.micinf.2024.105341}
}
Kostenlos starten →